ArticleCancer immunology, immunotherapy : CII2007

Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER.

Farah Aladin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.